Hemispherx to distribute second lot of Ampligen® for use in multiple indications
Hemispher announced regulatory inspection and clearance for distribution of the Company's second commercial scale lot of Ampligen® (rintatolimod), which is slated for multiple uses including product launch in Argentina, the U.S. and Europe. September 18, 2018